The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics.
about
Novel aqueous nano-scaled formulations of oleic acid stabilized hydrophobic superparamagnetic iron oxide nanocrystals.L-arginine hydrochloride increases the solubility of folded and unfolded recombinant plasminogen activator rPA.Fluorescence single particle tracking for the characterization of submicron protein aggregates in biological fluids and complex formulations.Characterization of superparamagnetic iron oxide nanoparticles by asymmetrical flow-field-flow-fractionation.Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheresIn situ microfluidic dialysis for biological small-angle X-ray scattering.Analysis of liposomes using asymmetrical flow field-flow fractionation: separation conditions and drug/lipid recovery.Asymmetrical flow field-flow fractionation with on-line detection for drug transfer studies: a feasibility study.Polymorphic fibrillation of the destabilized fourth fasciclin-1 domain mutant A546T of the Transforming growth factor-β-induced protein (TGFBIp) occurs through multiple pathways with different oligomeric intermediates.Impact of carrier fluid composition on recovery of nanoparticles and proteins in flow field flow fractionation.A bayesian approach for quantifying trace amounts of antibody aggregates by sedimentation velocity analytical ultracentrifugation.Characterization and purification of polydisperse reconstituted lipoproteins and nanolipoprotein particles.Strategies for the assessment of protein aggregates in pharmaceutical biotech product developmentFlow field-flow fractionation: recent trends in protein analysis.State-of-the-art analytical methods for assessing dynamic bonding soft matter materials.Characterization of seed nuclei in glucagon aggregation using light scattering methods and field-flow fractionation.Sensitive spectroscopic detection of large and denatured protein aggregates in solution by use of the fluorescent dye Nile red.Taylor dispersion analysis compared to dynamic light scattering for the size analysis of therapeutic peptides and proteins and their aggregates.Feasibility of asymmetric flow field-flow fractionation coupled to ICP-MS for the characterization of wear metal particles and metalloproteins in biofluids from hip replacement patients.Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation.PP3 forms stable tetrameric structures through hydrophobic interactions via the C-terminal amphipathic helix and undergoes reversible thermal dissociation and denaturation
P2860
Q30318148-3EFE47CF-2D6E-423D-908B-63AF6BDB5E11Q30318611-74D77187-AF42-4A94-8489-6139F9628CDEQ30499391-6F01BCF4-A89C-4ED1-94A1-67EFC3B98A3CQ33359261-DBAACC5C-63CF-446B-8C49-0382DA302ED3Q33691195-77520547-CCF1-4F49-B9A1-833774284BBEQ33994183-68A64F12-9AB2-4E22-BD32-2AA0A28B2010Q34367067-D506602C-A001-4EE4-AED2-0CA6F18765F1Q35092346-5A6436DF-ECEE-4A6E-AC8A-AEFEF1438652Q36298504-AEFAA871-2196-4171-99EA-8E6497BDF673Q36350272-BB06EAFE-1FAA-4AC7-97A4-317651AFC408Q37228319-8BACF02C-ECDE-4839-9D32-080D0ABF8705Q37335401-34519A6E-7A83-49EC-A790-8834374EEEC9Q37802771-3E53F60B-7C1B-4AEB-B1B3-044A34707928Q37806643-7D54E480-7922-4432-94B6-F7BD057D193EQ38208285-DCE4F726-9943-488E-AC6A-0C41FBC3BCE9Q40880350-FE2493FD-FF15-448F-BB7E-F01C32006B94Q41768509-DF0469BA-8E1D-4C56-9A85-68F0F71754CAQ41838506-091B253A-86FA-4FBF-908B-BDE222CCDB80Q46743388-AC3C3983-730D-4924-B774-954261E39165Q49829985-8666E9AF-D158-4F05-8323-245FCA03F934Q57823046-C52A0998-11B5-4EA4-9CF9-4A7D74BB4750
P2860
The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The use of asymmetrical flow f ...... aceutics and biopharmaceutics.
@ast
The use of asymmetrical flow f ...... aceutics and biopharmaceutics.
@en
type
label
The use of asymmetrical flow f ...... aceutics and biopharmaceutics.
@ast
The use of asymmetrical flow f ...... aceutics and biopharmaceutics.
@en
prefLabel
The use of asymmetrical flow f ...... aceutics and biopharmaceutics.
@ast
The use of asymmetrical flow f ...... aceutics and biopharmaceutics.
@en
P1476
The use of asymmetrical flow f ...... aceutics and biopharmaceutics.
@en
P2093
Gerhard Winter
Wolfgang Fraunhofer
P304
P356
10.1016/J.EJPB.2004.03.034
P407
P577
2004-09-01T00:00:00Z